The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
- PMID: 10823891
- PMCID: PMC18731
- DOI: 10.1073/pnas.100110097
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
Abstract
Huntington's Disease (HD) is caused by an expansion of a polyglutamine tract within the huntingtin (htt) protein. Pathogenesis in HD appears to include the cytoplasmic cleavage of htt and release of an amino-terminal fragment capable of nuclear localization. We have investigated potential consequences to nuclear function of a pathogenic amino-terminal region of htt (httex1p) including aggregation, protein-protein interactions, and transcription. httex1p was found to coaggregate with p53 in inclusions generated in cell culture and to interact with p53 in vitro and in cell culture. Expanded httex1p represses transcription of the p53-regulated promoters, p21(WAF1/CIP1) and MDR-1. httex1p was also found to interact in vitro with CREB-binding protein (CBP) and mSin3a, and CBP to localize to neuronal intranuclear inclusions in a transgenic mouse model of HD. These results raise the possibility that expanded repeat htt causes aberrant transcriptional regulation through its interaction with cellular transcription factors which may result in neuronal dysfunction and cell death in HD.
Figures
Comment in
-
Novel therapies in the search for a cure for Huntington's disease.Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):3-4. doi: 10.1073/pnas.98.1.3. Proc Natl Acad Sci U S A. 2001. PMID: 11136240 Free PMC article. No abstract available.
Similar articles
-
The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.Neuron. 2005 Jul 7;47(1):1-3. doi: 10.1016/j.neuron.2005.06.023. Neuron. 2005. PMID: 15996541
-
Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.Hum Mol Genet. 2012 Aug 1;21(15):3474-88. doi: 10.1093/hmg/dds178. Epub 2012 May 15. Hum Mol Genet. 2012. PMID: 22589249 Free PMC article.
-
Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.Hum Mol Genet. 2003 Jan 1;12(1):1-12. doi: 10.1093/hmg/ddg002. Hum Mol Genet. 2003. PMID: 12490527
-
Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.EMBO Rep. 2004 Oct;5(10):958-63. doi: 10.1038/sj.embor.7400250. EMBO Rep. 2004. PMID: 15459747 Free PMC article. Review.
-
Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.Biochem Soc Trans. 2009 Dec;37(Pt 6):1270-5. doi: 10.1042/BST0371270. Biochem Soc Trans. 2009. PMID: 19909260 Review.
Cited by
-
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.Int J Mol Sci. 2023 Nov 27;24(23):16798. doi: 10.3390/ijms242316798. Int J Mol Sci. 2023. PMID: 38069121 Free PMC article. Review.
-
Vaccinia-Related Kinase 2 Controls the Stability of the Eukaryotic Chaperonin TRiC/CCT by Inhibiting the Deubiquitinating Enzyme USP25.Mol Cell Biol. 2015 May;35(10):1754-62. doi: 10.1128/MCB.01325-14. Epub 2015 Mar 9. Mol Cell Biol. 2015. PMID: 25755282 Free PMC article.
-
A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.Front Mol Neurosci. 2022 Sep 14;15:974167. doi: 10.3389/fnmol.2022.974167. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36187346 Free PMC article. Review.
-
Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation.EMBO J. 2007 Mar 7;26(5):1385-96. doi: 10.1038/sj.emboj.7601592. Epub 2007 Feb 22. EMBO J. 2007. PMID: 17318184 Free PMC article.
-
Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets.Cell Mol Life Sci. 2022 May 3;79(5):274. doi: 10.1007/s00018-022-04280-8. Cell Mol Life Sci. 2022. PMID: 35503478 Free PMC article. Review.
References
-
- Harper P S, editor. Huntington's Disease. London: W. B. Saunders; 1991. pp. 141–178.
-
- The Huntington's Disease Collaborative Research Group. Cell. 1993;72:971–983. - PubMed
-
- DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Yound C, Martin E, Vonsattel J-P, Carraway R, Reeves S A, Boyce F M, Aronin N. Neuron. 1995;14:1075–1081. - PubMed
-
- Gusella J F, MacDonald M E. Semin Cell Biol. 1995;6:21–28. - PubMed
-
- Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies S W, Bates G P. Cell. 1996;87:493–506. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
